190 related articles for article (PubMed ID: 12773685)
1. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US.
LaTrenta LR; Menell JH; Morris EA; Abramson AF; Dershaw DD; Liberman L
Radiology; 2003 Jun; 227(3):856-61. PubMed ID: 12773685
[TBL] [Abstract][Full Text] [Related]
2. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography.
Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC
Breast J; 2015; 21(6):579-87. PubMed ID: 26390913
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Berg WA; Gutierrez L; NessAiver MS; Carter WB; Bhargavan M; Lewis RS; Ioffe OB
Radiology; 2004 Dec; 233(3):830-49. PubMed ID: 15486214
[TBL] [Abstract][Full Text] [Related]
4. Histological assessment of breast lesions identified exclusively by magnetic resonance.
O'Connor V; Arena E; Albright J; Brown N; O'Connor R; Chung M; DiNome M; Shamonki J
Am Surg; 2014 Oct; 80(10):944-7. PubMed ID: 25264635
[TBL] [Abstract][Full Text] [Related]
5. Role of second-look ultrasound examinations for MR-detected lesions in patients with breast cancer.
Lee SH; Kim SM; Jang M; Yun BL; Kang E; Kim SW; Park SY; Ahn HS; Chang JH; Yoo Y; Song TK; Moon WK
Ultraschall Med; 2015 Apr; 36(2):140-8. PubMed ID: 25750138
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Apr; 180(4):901-10. PubMed ID: 12646427
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ.
Soderstrom CE; Harms SE; Copit DS; Evans WP; Savino DA; Krakos PA; Farrell RS; Flamig DP
Radiology; 1996 Nov; 201(2):427-32. PubMed ID: 8888235
[TBL] [Abstract][Full Text] [Related]
8. MR-guided vacuum-assisted breast biopsy: is it an essential technique?
Tozaki M; Yamashiro N; Suzuki T; Kawano N; Ozaki S; Sakamoto N; Abe S; Ogawa T; Katayama N; Tsunoda Y; Fukuma E
Breast Cancer; 2009; 16(2):121-5. PubMed ID: 18807122
[TBL] [Abstract][Full Text] [Related]
9. Factors that impact the upgrading of atypical ductal hyperplasia.
Gümüş H; Mills P; Gümüş M; Fish D; Jones S; Jones P; Devalia H; Sever A
Diagn Interv Radiol; 2013; 19(2):91-6. PubMed ID: 23019055
[TBL] [Abstract][Full Text] [Related]
10. Ductal enhancement on MR imaging of the breast.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Aug; 181(2):519-25. PubMed ID: 12876038
[TBL] [Abstract][Full Text] [Related]
11. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
12. MR imaging of ductal carcinoma in situ.
Orel SG; Mendonca MH; Reynolds C; Schnall MD; Solin LJ; Sullivan DC
Radiology; 1997 Feb; 202(2):413-20. PubMed ID: 9015067
[TBL] [Abstract][Full Text] [Related]
13. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
Giess CS; Keating DM; Osborne MP; Rosenblatt R
Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of MR-guided Vacuum-Assisted Breast Biopsy: 8 Years of Experience.
Ferré R; Ianculescu V; Ciolovan L; Mathieu MC; Uzan C; Canale S; Delaloge S; Dromain C; Balleyguier C
Breast J; 2016; 22(1):83-9. PubMed ID: 26511082
[TBL] [Abstract][Full Text] [Related]
16. Mammographic, US, and MR imaging phenotypes of familial breast cancer.
Schrading S; Kuhl CK
Radiology; 2008 Jan; 246(1):58-70. PubMed ID: 18096529
[TBL] [Abstract][Full Text] [Related]
17. MRI of occult breast carcinoma in a high-risk population.
Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
[TBL] [Abstract][Full Text] [Related]
18. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
19. Breast lesions detected on MR imaging: features and positive predictive value.
Liberman L; Morris EA; Lee MJ; Kaplan JB; LaTrenta LR; Menell JH; Abramson AF; Dashnaw SM; Ballon DJ; Dershaw DD
AJR Am J Roentgenol; 2002 Jul; 179(1):171-8. PubMed ID: 12076929
[TBL] [Abstract][Full Text] [Related]
20. Targeted ultrasound for MR-detected lesions in breast cancer patients.
Shin JH; Han BK; Choe YH; Ko K; Choi N
Korean J Radiol; 2007; 8(6):475-83. PubMed ID: 18071277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
